3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

Abstract Background Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but wee...

Descripció completa

Dades bibliogràfiques

Autors principals:	Seth Helfenstein, Oliver Riesterer, Urs R. Meier, Alexandros Papachristofilou, Benjamin Kasenda, Miklos Pless, Sacha I. Rothschild
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2019-02-01
Col·lecció:	Radiation Oncology
Matèries:	Head and neck squamous carcinoma Chemo-radiotherapy Treatment Cisplatin Dose
Accés en línia:	http://link.springer.com/article/10.1186/s13014-019-1235-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!